Today: 7 November 2025
Subscribe
MMTec (MTC) soars 627% and then whipsaws pre‑market as Nasdaq delisting clock ticks — What to know today (Nov. 6, 2025)
 ·  ·  ·  ·  · 

MMTec (MTC) soars 627% and then whipsaws pre‑market as Nasdaq delisting clock ticks — What to know today (Nov. 6, 2025)

by
6 November 2025

Micro‑cap MMTec, Inc. (NASDAQ: MTC) was the talk of the tape after a +626.97% explosion on Wednesday, Nov. 5, followed by a sharp pre‑market giveback early today. The fireworks come with a looming Nasdaq delisting determination tied to MTC’s minimum bid price deficiency and last year’s reverse split. Here’s the latest, what’s driving the move, and what to watch next. [1]

What happened

  • Wednesday’s moonshot: On Nov. 5, MMTec finished as one of Nasdaq’s most eye‑popping movers, up roughly 627% on the day, according to same‑day market roundups published this morning. [2]
  • Thursday’s whipsaw: By 7:05 a.m. ET today (Nov. 6), Benzinga listed MTC among tech names sliding in pre‑market trading (about –24% around $1.68), underscoring the stock’s extreme volatility before the opening bell. Later quotes fluctuated widely through the morning. [3]
  • Live snapshot: As of 14:06 UTC today, the finance tape showed MTC around $2.21 (intraday levels remain highly fluid). (See live chart above.)

The delisting cloud driving the story

  • Nasdaq notice (Oct. 28): MMTec disclosed a Nasdaq determination to delist its securities for failing to meet the $1.00 minimum bid price. Because the company effected a 1‑for‑8 reverse split on Dec. 18, 2024, it’s ineligible for the standard 180‑day cure period under Nasdaq Listing Rule 5810(c)(3)(A)(iv). [4]
  • What that means right now: Per the company’s disclosure, trading would have been suspended at the open on Nov. 5 unless MMTec requested a hearing by Nov. 3. A timely hearing request stays any suspension while a Nasdaq Hearings Panel reviews the case. (The press release states the company intends to appeal; as a rule, such a request, if made, temporarily keeps trading active until a decision.) [5]

Bottom line: The binary, event‑driven setup around a potential Nasdaq hearing is a key backdrop for the outsized moves you’re seeing this week.

By the numbers (context for today)

  • Shares/float: About 25.19M shares outstanding; float ~25.14M, per recent statistics pages. That means the stock can still move violently on bursts of volume, despite not being an ultra‑tiny float. [6]
  • Market cap (approx.): At ~$2.21/share and ~25.19M shares outstanding, MMTec’s market value is ~$55.6M—micro‑cap territory. (Consistent with third‑party trackers.) [7]
  • Reverse split history:1‑for‑8 reverse split became effective Dec. 18, 2024, with trading continuing on Nasdaq under MTC. Reverse splits often reduce share count but do not change fundamentals, and can increase price volatility. [8]

Why is MTC moving so much?

  • Event risk + micro‑cap dynamics: The delisting timeline and the possibility (or outcome) of a Nasdaq hearing are central catalysts. Micro‑caps with small market values can be highly sensitive to flows, headlines and liquidity—leading to outsized daily swings in both directions. Wednesday’s extreme gain and today’s pre‑market giveback are consistent with that profile. [9]
  • No new fundamental update this morning: As of publication, the most recent formal company notice remains the Oct. 28 delisting determination and related hearing window; no fresh 6‑K or company press release for Nov. 6 has been posted on primary channels reviewed. [10]

What to watch next

  1. Hearing status & calendar: Whether a hearing was timely requested (and, if so, the scheduled date)—this determines whether trading remains active on Nasdaq while the Panel deliberates. Look for company updates via press releases and SEC 6‑K filings. [11]
  2. Potential outcomes:
    • Stay in effect pending decision (if a hearing was requested), with volatility likely to persist, or
    • Suspension and Form 25‑NSE filing if a stay is not in place or if the appeal fails—followed by potential OTC trading. (The company’s own Oct. 28 notice outlines these paths.) [12]
  3. Liquidity/halts: Given recent price action, be alert to LULD volatility halts and thin order books typical of micro‑caps.
  4. Follow‑on corporate actions: Any new capital measures (e.g., financings, further corporate actions) could alter float dynamics or sentiment.

Company background (for readers new to MMTec)

MMTec describes itself as Hong Kong–based, focusing on investment banking and asset management services, providing clients with “one‑stop” financial services. This description appears in the company’s official disclosures and press releases. [13]

Today’s MMTec headlines & sources at a glance

  • Nov. 6, 2025: Pre‑market movers — MTC down ~24% pre‑open around $1.68 (7:05 a.m. ET). [14]
  • Nov. 6, 2025: “Company News for Nov 6, 2025” recap highlighting MTC’s ~627% jump on Nov. 5. [15]
  • Nov. 5, 2025 (covered today): Market roundup notes MTC +626.9737% among top Nasdaq gainers. [16]
  • Oct. 28, 2025:Nasdaq delisting determination; hearing request by Nov. 3 would stay suspension pending a decision. [17]
  • Dec. 18, 2024:1‑for‑8 reverse split effective. [18]

Editor’s note & risk disclosure

This article is for information only and does not constitute investment advice. Micro‑cap stocks like MTC can experience extreme volatility and liquidity risk. Always do your own research and consider speaking with a licensed financial advisor.

MMTec (MTC) JUMP 627% in ONE DAY — The Wildest Pump of 2025!
Watch this video on YouTube.

References

1. m.economictimes.com, 2. m.economictimes.com, 3. www.benzinga.com, 4. www.nasdaq.com, 5. www.nasdaq.com, 6. stockanalysis.com, 7. www.wallstreetzen.com, 8. www.prnewswire.com, 9. www.nasdaq.com, 10. www.nasdaq.com, 11. www.nasdaq.com, 12. www.nasdaq.com, 13. www.prnewswire.com, 14. www.benzinga.com, 15. finance.yahoo.com, 16. m.economictimes.com, 17. www.nasdaq.com, 18. www.prnewswire.com

Tags:

Mateusz Kaczmarek Latest posts

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

  1. Brighthouse Financial (BHF) to Be Acquired by Aquarian Capital for $4.1B at $70/Share; Stock Jumps — Nov. 6, 2025
  2. HubSpot (HUBS) Plunges ~18% After Q3 Beat: Raised 2025 Guidance, New AI Push, and Meta’s Clara Shih Joins the Board [Nov. 6, 2025]
  3. SiTime (SITM) Stock Jumps After Q3 2025 Beat; Company Guides Q4 Revenue to $100–$103M on AI Data‑Center Demand
  4. Hecla Mining (HL) Soars on Record Q3 2025: $409.5M Revenue, $0.15 EPS, Dividend Declared — What to Know Today (Nov 6, 2025)

Stock Market Today

  • Figs (NYSE:FIGS) Q3 Beat on Revenue, EBITDA; Shares Jump ~16% on Strong Results
    November 7, 2025, 12:36 AM EST. Figs (NYSE:FIGS) posted a stronger-than-expected Q3 CY2025 as revenue rose to $151.7 million, up 8.2% YoY and ahead of estimates of $142.5 million. The company reported an Adjusted EPS of $0.05, well above consensus of $0.02, and Adjusted EBITDA of $18.85 million versus $12.38 million expected. The operating margin improved to 6.4% from -6.2% a year earlier. However, free cash flow margin slipped to 0.4% from 13.1% in the year-ago quarter. Active customers reached 2.78 million, up 108k YoY. With a $1.24 billion market cap, the stock's move reflected investor enthusiasm as shares jumped ~16% following the results. Sell-side revenue guidance looks flat over the next 12 months, suggesting some near-term headwinds despite profitability gains.
  • Globus Medical Q3 Beat Lifts Guidance; GMED Stock Rises on Strong Results
    November 7, 2025, 12:34 AM EST. Globus Medical (GMED) reported a solid Q3 CY2025, with revenue of $769 million, up 22.9% YoY, and a 4.7% beat versus estimates. Its non-GAAP EPS of $1.18 eclipsed consensus by 53.4%, and Adjusted EBITDA reached $252.6 million, a beat of about 27.3%. The company lifted its full-year revenue guidance to a midpoint of $2.88 billion and raised Adjusted EPS to $3.80. The operating margin expanded to 17.9% from 7.7%, while free cash flow margin rose to 27.8%. Constant-currency growth was 22.3% YoY. With operations in 64 countries and a broad spine/orthopedic/neurosurgical portfolio, the quarter reinforces a durable growth trajectory for GMED.
  • NVIDIA Stock Drops 3.7% as Insiders Sell Big: CFO Colette Kress and CEO Jen Hsun Huang Trim Stakes
    November 7, 2025, 12:32 AM EST. NVDA shares fell about 3.7% on Thursday after notable insider selling surfaced. The stock traded as low as $186.38 and was last at $188.08, with about 220,077,580 shares changing hands vs. the 226,128,344 average. CFO Colette Kress sold 20,000 shares at $208.33 (≈$4.17 million), cutting her stake to 123,060 shares. A second sale of 27,640 shares at the same price reduced ownership by ~0.97% to 2,828,122 shares (≈$589.2 million). CEO Jen Hsun Huang sold 25,000 shares at $207.91, leaving him with 69,733,203 shares (≈$14.5 billion). On the sentiment side, analysts remain constructive: Truist, Piper Sandler, Jefferies, Citigroup, and Bank of America raised targets or reiterated Buy/Overweight ratings. Market consensus shows a mix: 5 Strong Buy, 41 Buy, 2 Hold, 1 Sell.
  • Tesla 2026 Supercycle: 5 Catalysts That Could Ignite TSLA
    November 7, 2025, 12:30 AM EST. Tesla's 2026 thesis centers on five bullish catalysts that could lift TSLA despite a transitional period. The piece argues that stocks move on future-forward information, not just current price, and that Tesla's strength lies in disruptive product announcements and software-led upgrades. The five catalysts highlighted include the Robotaxi network powered by FSD and a Cybercab rollout; ongoing cash generation even before new products fully scale; a shift away from the legacy EV business toward high-margin software and services; a broader product and AI roadmap that re-accelerates growth; and potential regulatory, manufacturing, or market catalysts that could force a valuation re-rating. If Musk's vision translates into realized deployments and expanding margins, the stock could experience a large valuation re-rating.
  • Evolent Health Beats Q3 Revenue, Stock Jumps 14.8% on Mixed Results
    November 7, 2025, 12:28 AM EST. Evolent Health (EVH) beat Wall Street on Q3 revenue, generating $479.5 million vs $467.3 million estimates, though year-over-year demand declined 22.8%. The adjusted EPS of $0.05 missed estimates of $0.11 (a 52.5% miss). Adjusted EBITDA came in at $38.96 million, slightly above consensus ($37.67 million). The company guided Q4 revenue of $467 million at the midpoint, below calls for about $472.9 million, and full-year EBITDA guidance of $149 million vs $151.7 million expected. Operating margin improved to 0.2% from -2.6% a year ago; free cash flow margin steady at 1.4%. CEO Seth Blackley cited new contracts (13 this year) and a planned ECP transaction to reduce debt, with a longer-term forecast of $2.5 billion revenue in 2026. Shares rose roughly 14.8%.
Comstock Resources (CRK) Jumps as Q3 Results, $430M Divestiture and Rising RS Rating Put Haynesville Gas in Focus — Nov. 6, 2025
Previous Story

Comstock Resources (CRK) Jumps as Q3 Results, $430M Divestiture and Rising RS Rating Put Haynesville Gas in Focus — Nov. 6, 2025

ConocoPhillips (COP) beats Q3, hikes dividend 8%, lifts 2025 output; Willow budget raised to up to $9B — Nov. 6, 2025
Next Story

ConocoPhillips (COP) beats Q3, hikes dividend 8%, lifts 2025 output; Willow budget raised to up to $9B — Nov. 6, 2025

Related Articles

Go toTop